Atlas Trials

An Extension Study to Demonstrate the Equivalence of Long-Term Efficacy and Safety of CT-P13 in Patients With Ankylosing Spondylitis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 1.1

Clinical trial NCT01571206 · COMPLETED

Trial details

NCT number
NCT01571206
Sponsor
Celltrion
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Ankylosing Spondylitis
Start date
2012-03-01
Primary completion
2013-05-01
Enrollment
174

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.